Belén Garijo/LinkedIn
May 19, 2025, 08:12
Belén Garijo Reports Q1 Results and Sustained Growth at Merck
Belén Garijo, Chair of the Executive Board and CEO of Merck — shared on LinkedIn:
“Today, we published our Q1 results! I am proud to share that we are continuing to deliver profitable growth across all three businesses.
These results highlight the resilience of our diverse, innovation-driven business, further supported by our region-for-region approach.
Looking ahead, we are operating in the midst of a challenging macro-economic as well as geopolitical environment and are therefore slightly adjusting our guidance for the full year.
Our key message is clear: We remain confident to achieve sustainable profitable growth for 2025.”
Belén Garijo shared Merck’s Q1 financial performance, underlining growth across its business segments despite macroeconomic and geopolitical pressures.
The company remains focused on delivering sustainable profitability into 2025.
You Can Find More Posts Featuring Belén Garijo on OncoDaily
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jul 1, 2025, 10:32
Jul 1, 2025, 09:57
Jul 1, 2025, 09:25